share_log

卫信康(603676.SH):子公司获得多种微量元素注射液(Ⅲ)药品注册证书

Tibet Weixinkang Pharmaceutical (603676.SH): Subsidiary obtains registration certificate for multiple trace element injection (III) pharmaceuticals.

Gelonghui Finance ·  Jul 16 03:46

On July 16th, Gelunhui announced that Tibet Weixinkang Pharmaceutical (603676.SH), its wholly-owned subsidiary Yangpu Jingtai Pharmaceutical Co., Ltd. (referred to as Yangpu Jingtai), has received the Drug Registration Certificate for multiple trace element injections (Ⅲ) approved and issued by the National Medical Products Administration. Multiple trace element injections (Ⅲ) are a trace element supplement used to meet the basic and intermediate needs of patients for trace elements during intravenous nutrition.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment